DE60024612D1 - Verfahren zur herstellung von konditionierten zellkulturmedium-zusammensetzungen - Google Patents
Verfahren zur herstellung von konditionierten zellkulturmedium-zusammensetzungenInfo
- Publication number
- DE60024612D1 DE60024612D1 DE60024612T DE60024612T DE60024612D1 DE 60024612 D1 DE60024612 D1 DE 60024612D1 DE 60024612 T DE60024612 T DE 60024612T DE 60024612 T DE60024612 T DE 60024612T DE 60024612 D1 DE60024612 D1 DE 60024612D1
- Authority
- DE
- Germany
- Prior art keywords
- medium
- conditioned
- cell culture
- culture medium
- medium compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 230000001143 conditioned effect Effects 0.000 title abstract 5
- 239000000203 mixture Substances 0.000 title abstract 3
- 239000006143 cell culture medium Substances 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000002609 medium Substances 0.000 abstract 6
- 210000004027 cell Anatomy 0.000 abstract 2
- 239000002674 ointment Substances 0.000 abstract 2
- 239000012141 concentrate Substances 0.000 abstract 1
- 239000003636 conditioned culture medium Substances 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 210000003527 eukaryotic cell Anatomy 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
- 239000003981 vehicle Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/33—Fibroblasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1825—Fibroblast growth factor [FGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0208—Tissues; Wipes; Patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
- A61K8/985—Skin or skin outgrowth, e.g. hair, nails
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/043—Proteins; Polypeptides; Degradation products thereof
- A61L31/044—Collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/043—Proteins; Polypeptides; Degradation products thereof
- A61L31/047—Other specific proteins or polypeptides not covered by A61L31/044 - A61L31/046
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0625—Epidermal cells, skin cells; Cells of the oral mucosa
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0625—Epidermal cells, skin cells; Cells of the oral mucosa
- C12N5/0629—Keratinocytes; Whole skin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0656—Adult fibroblasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/069—Vascular Endothelial cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/86—Products or compounds obtained by genetic engineering
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/91—Injection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
- A61L2300/414—Growth factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/36—Materials or treatment for tissue regeneration for embolization or occlusion, e.g. vaso-occlusive compositions or devices
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
- C12N2502/1323—Adult fibroblasts
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/313,538 US6372494B1 (en) | 1999-05-14 | 1999-05-14 | Methods of making conditioned cell culture medium compositions |
US313538 | 1999-05-14 | ||
PCT/US2000/013016 WO2000069449A2 (en) | 1999-05-14 | 2000-05-12 | Conditioned cell culture medium compositions and methods of use |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60024612D1 true DE60024612D1 (de) | 2006-01-12 |
DE60024612T2 DE60024612T2 (de) | 2006-09-14 |
Family
ID=23216124
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60024612T Expired - Lifetime DE60024612T2 (de) | 1999-05-14 | 2000-05-12 | Verfahren zur herstellung von konditionierten zellkulturmedium-zusammensetzungen |
Country Status (16)
Country | Link |
---|---|
US (12) | US6372494B1 (de) |
EP (1) | EP1178812B1 (de) |
JP (2) | JP5138129B2 (de) |
CN (1) | CN1198628C (de) |
AT (1) | ATE311894T1 (de) |
AU (1) | AU772829C (de) |
BR (1) | BR0010568A (de) |
CA (1) | CA2373302C (de) |
DE (1) | DE60024612T2 (de) |
ES (1) | ES2254176T3 (de) |
HU (1) | HUP0201887A2 (de) |
MX (1) | MXPA01011487A (de) |
NZ (1) | NZ515476A (de) |
RU (1) | RU2280459C2 (de) |
WO (1) | WO2000069449A2 (de) |
ZA (1) | ZA200109381B (de) |
Families Citing this family (312)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6667176B1 (en) * | 2000-01-11 | 2003-12-23 | Geron Corporation | cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells |
US7410798B2 (en) | 2001-01-10 | 2008-08-12 | Geron Corporation | Culture system for rapid expansion of human embryonic stem cells |
US20030007954A1 (en) * | 1999-04-12 | 2003-01-09 | Gail K. Naughton | Methods for using a three-dimensional stromal tissue to promote angiogenesis |
US6372494B1 (en) * | 1999-05-14 | 2002-04-16 | Advanced Tissue Sciences, Inc. | Methods of making conditioned cell culture medium compositions |
CA2383398C (en) * | 1999-08-23 | 2013-06-11 | Organogenesis, Inc. | Skin care compositions and treatments |
DE10005329A1 (de) * | 2000-02-08 | 2001-09-20 | Albert Scheller | Humanisiertes, vitalisiertes Haarbewachsen und Haarwiederbewachsen mit subkutanen Kanüleneinstich-Haut-Färbungs-Zeichnungsverfahren |
IL136232A0 (en) * | 2000-05-18 | 2001-05-20 | Bar Ilan University Res Author | Measurements of enzymatic activity in a single, individual cell in population |
WO2001091773A2 (en) * | 2000-05-31 | 2001-12-06 | Encelle, Inc. | Method of stimulating hair growth |
WO2002059278A2 (en) * | 2001-01-24 | 2002-08-01 | The Government Of The United States Of America, As Represented By The Secretary Of Department Of Health & Human Services | Differentiation of stem cells to pancreatic endocrine cells |
US20030211605A1 (en) * | 2001-05-01 | 2003-11-13 | Lee Sang-Hun | Derivation of midbrain dopaminergic neurons from embryonic stem cells |
WO2002098365A2 (en) * | 2001-06-07 | 2002-12-12 | Skinmedica, Inc. | Conditioned cell culture media and uses thereof |
JP2003012525A (ja) * | 2001-07-02 | 2003-01-15 | Hoshizaki Electric Co Ltd | 生体の損傷部位用の洗浄水およびその製造装置 |
US20030068297A1 (en) * | 2001-08-18 | 2003-04-10 | Deepak Jain | Composition and methods for skin rejuvenation and repair |
US20040265268A1 (en) * | 2001-08-18 | 2004-12-30 | Deepak Jain | Compositions and methods for skin rejuvenation and repair |
EP2332651A3 (de) * | 2001-10-25 | 2011-08-31 | Bar Ilan University | Interaktiver transparenter Biochip-Prozessor für einzeln adressierbare Zellen |
WO2003057152A2 (en) * | 2001-12-31 | 2003-07-17 | Isolagen Technologies, Inc | Hair follicle growth |
WO2004007699A2 (en) * | 2002-07-16 | 2004-01-22 | Biogentis Inc. | Method for preparing engineered tissue |
WO2004011631A2 (en) * | 2002-07-26 | 2004-02-05 | Ebi, L.P. | Methods and compositions for treating tissue defects using pulsed electromagnetic field stimulus |
US20050019747A1 (en) * | 2002-08-07 | 2005-01-27 | Anderson Daniel G. | Nanoliter-scale synthesis of arrayed biomaterials and screening thereof |
US7338433B2 (en) | 2002-08-13 | 2008-03-04 | Allergan, Inc. | Remotely adjustable gastric banding method |
JP2005536214A (ja) * | 2002-08-22 | 2005-12-02 | セルトラン リミテッド | 細胞培養表面 |
DE60331457D1 (de) | 2002-08-28 | 2010-04-08 | Allergan Inc | Ermüdungsfeste magenbandvorrichtung |
US7785876B2 (en) * | 2002-11-14 | 2010-08-31 | Aderans Research Institute, Inc. | Cultivation of hair inductive cells |
IL154677A0 (en) * | 2003-02-27 | 2003-09-17 | Univ Bar Ilan | A method and apparatus for manipulating an individual cell |
AU2004227342B2 (en) * | 2003-04-01 | 2011-01-20 | United States Of America Department Of Veteran's Affairs | Stem-cell, precursor cell, or target cell-based treatment of multi-organ failure and renal dysfunction |
FR2861734B1 (fr) | 2003-04-10 | 2006-04-14 | Corneal Ind | Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus |
FR2853905A1 (fr) * | 2003-04-15 | 2004-10-22 | Corbin Assia Eljaafari | Production de cellules dendritiques humaines derivees de monocytes, a l'aide de cellules souches mesenchymateuses |
EP1475434A1 (de) * | 2003-05-09 | 2004-11-10 | Oncoscience AG | Verfahren zur Lagerung von Tumorzellen |
EP2340856B2 (de) * | 2003-05-24 | 2017-11-15 | La Prairie Group AG | Kosmetische oder dermatologische Zubereitung umfassend eine Nährmedienphase |
US9200245B2 (en) | 2003-06-26 | 2015-12-01 | Seng Enterprises Ltd. | Multiwell plate |
US8597597B2 (en) * | 2003-06-26 | 2013-12-03 | Seng Enterprises Ltd. | Picoliter well holding device and method of making the same |
US20060240548A1 (en) * | 2003-06-26 | 2006-10-26 | Mordechai Deutsch | Materials for constructing cell-chips, cell-chip covers, cell-chips coats, processed cell-chips and uses thereof |
US7888110B2 (en) * | 2003-06-26 | 2011-02-15 | Seng Enterprises Ltd. | Pico liter well holding device and method of making the same |
US7875272B2 (en) | 2003-06-27 | 2011-01-25 | Ethicon, Incorporated | Treatment of stroke and other acute neuraldegenerative disorders using postpartum derived cells |
US9572840B2 (en) | 2003-06-27 | 2017-02-21 | DePuy Synthes Products, Inc. | Regeneration and repair of neural tissue using postpartum-derived cells |
US8790637B2 (en) | 2003-06-27 | 2014-07-29 | DePuy Synthes Products, LLC | Repair and regeneration of ocular tissue using postpartum-derived cells |
US8491883B2 (en) * | 2003-06-27 | 2013-07-23 | Advanced Technologies And Regenerative Medicine, Llc | Treatment of amyotrophic lateral sclerosis using umbilical derived cells |
US8518390B2 (en) | 2003-06-27 | 2013-08-27 | Advanced Technologies And Regenerative Medicine, Llc | Treatment of stroke and other acute neural degenerative disorders via intranasal administration of umbilical cord-derived cells |
US8703121B2 (en) * | 2003-06-27 | 2014-04-22 | DePuy Synthes Products, LLC | Postpartum-derived cells for use in treatment of disease of the heart and circulatory system |
US9592258B2 (en) | 2003-06-27 | 2017-03-14 | DePuy Synthes Products, Inc. | Treatment of neurological injury by administration of human umbilical cord tissue-derived cells |
US7982751B2 (en) * | 2003-07-11 | 2011-07-19 | The University Of North Carolina | Methods and systems for controlling a computer using a video image and for combining the video image with a computer desktop |
IL156945A0 (en) * | 2003-07-15 | 2004-02-08 | Itzhak Tavori | Device and a method for orthopedic delivery of bone reconstruction medium |
US20050064524A1 (en) * | 2003-08-11 | 2005-03-24 | Mordechai Deutsch | Population of cells utilizable for substance detection and methods and devices using same |
ITRM20030395A1 (it) * | 2003-08-12 | 2005-02-13 | Istituto Naz Per Le Malattie Infettive Lazz | Terreno di coltura per il mantenimento, la proliferazione e il differenziamento di cellule di mammifero. |
WO2005016364A1 (en) * | 2003-08-14 | 2005-02-24 | Guthy-Renker Corporation | Skin care composition including hexapeptide complexes and methods of their manufacture |
US20060198800A1 (en) * | 2003-08-14 | 2006-09-07 | Natalie Dilallo | Skin care compositions including hexapeptide complexes and methods of their manufacture |
WO2005062791A2 (en) * | 2003-12-20 | 2005-07-14 | Jeffrey Sebastian | Utilization of stem cell and fibroblast combined products and nutrients in topical compositions |
PL380451A1 (pl) | 2004-01-23 | 2007-02-05 | Allergan, Inc. | Jednoelementowa regulowana opaska żołądkowa, mocowana z możliwością zwolnienia |
US7544805B2 (en) * | 2004-02-03 | 2009-06-09 | Chemagis Ltd. | Stable amorphous forms of montelukast sodium |
EP1718733A4 (de) * | 2004-02-06 | 2007-02-07 | Theradigm Inc | Zusammensetzungen und verfahren in verbindung mit der kultivierung neuraler stammzellen mit knochenmarksstromazellen |
MXPA06010204A (es) | 2004-03-08 | 2007-03-07 | Endoart Sa | Sistema de cierre para organos tubulares. |
US20080063251A1 (en) * | 2004-07-07 | 2008-03-13 | Mordechai Deutsch | Method and Device for Identifying an Image of a Well in an Image of a Well-Bearing |
US7403647B2 (en) * | 2004-09-13 | 2008-07-22 | Seng Enterprises Ltd. | Method for identifying an image of a well in an image of a well-bearing component |
WO2006021959A2 (en) * | 2004-08-25 | 2006-03-02 | Seng Enterprises Ltd. | Method and device for isolating cells |
US20060154365A1 (en) * | 2004-08-30 | 2006-07-13 | Anthony Ratcliffe | Cultured three dimensional tissues and uses thereof |
EP1789536A2 (de) * | 2004-08-30 | 2007-05-30 | IKEN Tissue Therapeutics, Inc. | Dreidimensionale kultivierte gewebe und deren verwendung |
WO2006029262A2 (en) * | 2004-09-08 | 2006-03-16 | Myocardial Therapeutics, Inc. | Conditioned medium of autologous or allogenic progenitor cells for angiogenesis treatment |
JP5031370B2 (ja) * | 2004-09-17 | 2012-09-19 | セルジェンテック株式会社 | 外用皮膚潰瘍治療剤 |
US20060095121A1 (en) * | 2004-10-28 | 2006-05-04 | Medtronic Vascular, Inc. | Autologous platelet gel on a stent graft |
US7993578B2 (en) | 2004-10-29 | 2011-08-09 | Depuy Spine, Inc. | Methods and kits for aseptic filling of products |
WO2006083394A2 (en) * | 2004-12-21 | 2006-08-10 | Ethicon, Inc. | Postpartum cells derived from placental tissue, and methods of making, culturing, and using the same |
US20060171930A1 (en) * | 2004-12-21 | 2006-08-03 | Agnieszka Seyda | Postpartum cells derived from umbilical cord tissue, and methods of making, culturing, and using the same |
US20060153815A1 (en) * | 2004-12-21 | 2006-07-13 | Agnieszka Seyda | Tissue engineering devices for the repair and regeneration of tissue |
CA2589063C (en) | 2004-12-23 | 2016-08-09 | Ethicon Incorporated | Treatment of parkinson's disease and related disorders using postpartum derived cells |
JP5340599B2 (ja) * | 2004-12-23 | 2013-11-13 | エシコン・インコーポレイテッド | 臍帯組織由来産褥細胞ならびにその製造方法および使用方法 |
US8038964B2 (en) * | 2005-01-25 | 2011-10-18 | Seng Enterprises Ltd. | Device for studying individual cells |
CN103356705B (zh) | 2005-03-31 | 2015-09-30 | 斯丹姆涅恩有限公司 | 制备用以治疗烧伤伤口的药物的方法 |
US8153430B2 (en) * | 2005-03-31 | 2012-04-10 | Stemnion, Inc. | Methods related to surgery |
US8251888B2 (en) | 2005-04-13 | 2012-08-28 | Mitchell Steven Roslin | Artificial gastric valve |
NZ536009A (en) * | 2005-04-18 | 2007-01-26 | Neurotrophincell Pty Ltd | Choroid plexus preparation and uses thereof |
US20090075375A1 (en) * | 2005-04-18 | 2009-03-19 | Neurotrophincell Pty Limited | Choroid plexus preparation and uses thereof |
WO2006121445A2 (en) * | 2005-05-10 | 2006-11-16 | United States Of America Department Of Veteran's Affairs | Therapy of kidney diseases and multiorgan failure with mesenchymal stem cells and mesenchymal stem cell conditioned media |
NZ540597A (en) * | 2005-06-08 | 2007-02-23 | Neurotrophincell Pty Ltd | A method for preventing the onset of type I diabetes comprising administering an implantable composition comprising living choroid plexus cells |
CA2612188A1 (en) * | 2005-06-17 | 2007-01-04 | Theregen, Inc. | Methods for treating ischemic tissue |
US20070003541A1 (en) * | 2005-07-01 | 2007-01-04 | Rodolfo Faudoa | Methods and compositions for therapeutics |
US20070128685A1 (en) * | 2005-07-01 | 2007-06-07 | Rodolfo Faudoa | Methods and compositions for cell culture |
US20070004036A1 (en) * | 2005-07-01 | 2007-01-04 | Rodolfo Faudoa | Methods and compositions for keratinocyte culture |
DE102005034043B4 (de) * | 2005-07-18 | 2019-12-12 | Südzucker Aktiengesellschaft Mannheim/Ochsenfurt | Gemisch, enthaltend L-Carnitin und Trehalulose, sowie Produkt enthaltend das Gemisch |
US20070141555A1 (en) * | 2005-10-11 | 2007-06-21 | Mordechai Deutsch | Current damper for the study of cells |
WO2007052245A1 (en) * | 2005-11-03 | 2007-05-10 | Seng Enterprises Ltd. | Method and device for studying floating, living cells |
US20070231901A1 (en) * | 2005-12-02 | 2007-10-04 | Shuichi Takayama | Microfluidic cell culture media |
RU2008128451A (ru) * | 2005-12-14 | 2010-01-20 | Огенодженесис, Инк. (US) | Композиция для лечения и ухода за кожей, способ ее получения, способ ее использования |
US9175261B2 (en) * | 2005-12-16 | 2015-11-03 | DePuy Synthes Products, Inc. | Human umbilical cord tissue cells for inhibiting adverse immune response in histocompatibility-mismatched transplantation |
ES2391034T3 (es) * | 2005-12-19 | 2012-11-20 | Ethicon, Inc. | Expansión in vitro de células derivadas postparto en frascos rotatorios |
US9125906B2 (en) | 2005-12-28 | 2015-09-08 | DePuy Synthes Products, Inc. | Treatment of peripheral vascular disease using umbilical cord tissue-derived cells |
US20070160588A1 (en) * | 2005-12-28 | 2007-07-12 | Ethicon, Incorporated | Treatment Of Peripheral Vascular Disease Using Postpartum-Derived Cells |
US8043206B2 (en) | 2006-01-04 | 2011-10-25 | Allergan, Inc. | Self-regulating gastric band with pressure data processing |
US8871198B2 (en) * | 2006-03-29 | 2014-10-28 | Stemnion, Inc. | Methods related to wound healing |
EP1974022B1 (de) * | 2006-01-27 | 2015-12-23 | Prostemics Co., Ltd. | Massenproduktionsverfahren für wachstumsfaktor unter verwendung von aus fettgewebe stammenden adulten stammzellen |
JP2009525837A (ja) * | 2006-02-07 | 2009-07-16 | オルガノジェネシス インク. | 生物工学処理された組織構築物およびその心臓での使用 |
WO2007097993A2 (en) * | 2006-02-16 | 2007-08-30 | The Burnham Institute Of Medical Research | Media conditioned by human embryonic stem cells or other progenitor cells and uses therefor |
US20110091568A1 (en) * | 2006-02-16 | 2011-04-21 | Lipton Stuart A | Media conditioned by stem cells and uses therefor |
EP2009096B8 (de) * | 2006-04-04 | 2017-01-25 | Trans-Technologies Ltd. | Biotransplantat für die zelltherapie auf der grundlage mesenchymaler knochenmark-stammzellen |
US20060223999A1 (en) * | 2006-05-10 | 2006-10-05 | Chemagis Ltd. | Process for preparing montelukast and precursors thereof |
FR2901136B1 (fr) * | 2006-05-18 | 2010-10-01 | Centre Nat Rech Scient | Utilisation de cellules derivees du tissu adipeux pour la preparation d'un medicament anti-tumoral |
US20080027212A1 (en) * | 2006-06-28 | 2008-01-31 | Skinner Keith K | Methods and compositions for improved uptake of biological molecules |
US20080166804A1 (en) * | 2006-07-14 | 2008-07-10 | Shamblott Michael J | Compostions and methods for growing human embryonic stem cells |
JP2007050263A (ja) * | 2006-08-23 | 2007-03-01 | Nipro Corp | 生体組織または器官再生用器具 |
WO2008027984A1 (en) | 2006-08-29 | 2008-03-06 | Isolagen Technologies, Inc. | Methods for culturing minimally-passaged fibroblasts and uses thereof |
EP2076589B1 (de) | 2006-10-02 | 2017-02-22 | Orthocell Limited | Verfahren zur herstellung nativer komponenten, wie etwa wachstumsfaktoren oder extrazellulärer matrixproteine, über zellkultivierung von gewebeproben für die gewebereparatur |
ES2583371T3 (es) | 2006-10-11 | 2016-09-20 | The General Hospital Corporation | Composiciones, métodos, y dispositivos para tratar enfermedades hepáticas |
WO2008067422A2 (en) * | 2006-11-28 | 2008-06-05 | Zgi, Inc. | Replication of undifferentiated diploid cells in a weightless environment, uses thereof and a facility for such replication |
EP2099901B1 (de) | 2006-11-30 | 2015-09-09 | Medipost, Co., Ltd. | Verwendung einer zusammensetzung mit aus menschlichem nabelschnurblut stammender mesenchymaler stammzelle zur induktion der differenzierung und proliferation neuraler vorläuferzellen oder neuraler stammzellen zu neuralen zellen |
WO2008070868A1 (en) * | 2006-12-07 | 2008-06-12 | American Symbolic, Llc | Stem cell secretions and related methods |
US20080311093A1 (en) * | 2006-12-07 | 2008-12-18 | American Symbolic, Llc | Stem cell secretions and related methods |
US20120034183A1 (en) * | 2006-12-19 | 2012-02-09 | Michael Cohen | Compositions and methods for growing embryonic stem cells |
US20100130415A1 (en) * | 2006-12-19 | 2010-05-27 | Michael Cohen | Stem cell secreted product derived compositions for wound treatment |
RU2341270C2 (ru) * | 2006-12-28 | 2008-12-20 | Александр Сергеевич Ботин | Композиция для стимулирования роста и регенерации клеток, а также способы ее получения |
ES2623141T3 (es) | 2007-01-17 | 2017-07-10 | Noveome Biotherapeutics, Inc. | Nuevos métodos para modular respuestas inflamatorias y/o inmunitarias |
KR100883565B1 (ko) * | 2007-02-14 | 2009-02-13 | (주)프로스테믹스 | 지방 줄기세포의 조직 재생 능력을 최적화한 조건 배지를 함유한 조직 재생용 주사제 첨가제 |
WO2008103462A2 (en) | 2007-02-23 | 2008-08-28 | Advanced Cell Technology, Inc. | Highly efficient methods for reprogramming differentiated cells and for generating animals and embryonic stem cells from reprogrammed cells |
EP2139447A2 (de) * | 2007-03-20 | 2010-01-06 | Harold Brem | Gm-csf-kosmezeutikazusammensetzungen und verfahren zu ihrer verwendung |
RU2007112288A (ru) * | 2007-04-03 | 2008-10-10 | Александр Сергеевич Ботин (RU) | Композиция для стимулирования роста и регенерации клеток, а также способ ее получения |
CA2629652A1 (en) * | 2007-04-24 | 2008-10-24 | Yaojiong Wu | Compositions for preventing or treating skin defects and methods of use thereof |
EP2152743A2 (de) * | 2007-05-23 | 2010-02-17 | Allergan, Inc. | Quervernetztes collagen und anwendungen davon |
CA2688504A1 (en) | 2007-06-18 | 2008-12-24 | Children's Hospital & Research Center At Oakland | Method of isolating stem and progenitor cells from placenta |
US20100129328A1 (en) * | 2007-07-24 | 2010-05-27 | Sing George L | Methods for promoting hair growth |
KR100848056B1 (ko) * | 2007-07-30 | 2008-07-23 | (주)프로스테믹스 | 줄기세포 배양액을 이용한 멜라닌 합성저해 방법 |
US8318695B2 (en) * | 2007-07-30 | 2012-11-27 | Allergan, Inc. | Tunably crosslinked polysaccharide compositions |
CN102036688B (zh) * | 2007-10-05 | 2014-07-02 | 伊西康公司 | 使用人脐带组织来源的细胞进行肾脏组织的修复和再生 |
US8697044B2 (en) | 2007-10-09 | 2014-04-15 | Allergan, Inc. | Crossed-linked hyaluronic acid and collagen and uses thereof |
US9975118B2 (en) | 2007-11-15 | 2018-05-22 | Seng Enterprises Ltd. | Device for the study of living cells |
US9145540B1 (en) | 2007-11-15 | 2015-09-29 | Seng Enterprises Ltd. | Device for the study of living cells |
JP5670196B2 (ja) | 2007-11-16 | 2015-02-18 | バイセプト セラピューティクス、インク. | 紫斑を治療する組成物および方法 |
US20090143348A1 (en) * | 2007-11-30 | 2009-06-04 | Ahmet Tezel | Polysaccharide gel compositions and methods for sustained delivery of drugs |
US8394784B2 (en) * | 2007-11-30 | 2013-03-12 | Allergan, Inc. | Polysaccharide gel formulation having multi-stage bioactive agent delivery |
US8394782B2 (en) * | 2007-11-30 | 2013-03-12 | Allergan, Inc. | Polysaccharide gel formulation having increased longevity |
US8236538B2 (en) * | 2007-12-20 | 2012-08-07 | Advanced Technologies And Regenerative Medicine, Llc | Methods for sterilizing materials containing biologically active agents |
US9101586B2 (en) * | 2007-12-28 | 2015-08-11 | Augustine Bader | Topical application and formulation of erythropoietin for skin wound healing |
US8535913B2 (en) * | 2008-01-30 | 2013-09-17 | Histogen, Inc. | Soluble composition for promoting hair growth produced by hypoxic culture of fibroblasts cells |
US8530415B2 (en) * | 2008-01-30 | 2013-09-10 | Histogen, Inc. | Repair and/or regeneration of cells with a composition produced by culturing fibroblast cells under hypoxic conditions |
SG10201500237TA (en) * | 2008-01-30 | 2015-04-29 | Histogen Inc | Extracellular matrix compositions |
US8524494B2 (en) | 2008-01-30 | 2013-09-03 | Histogen, Inc. | Low oxygen tension and BFGF generates a multipotent stem cell from a fibroblast in vitro |
US20100166824A1 (en) * | 2008-01-30 | 2010-07-01 | Histogen, Inc. | Extracellular matrix compositions |
EP2257272B1 (de) * | 2008-03-31 | 2013-09-25 | Scarcell Therapeutics | Verfahren zur kosmetischen behandlung von hautbehandlung bei lichtalterung |
US9820747B2 (en) * | 2008-04-04 | 2017-11-21 | The Cleveland Clinic Foundation | Use of epineural sheath grafts for neural regeneration and protection |
WO2009136747A2 (ko) | 2008-05-07 | 2009-11-12 | 한 쎌 주식회사 | 줄기세포 배양액을 포함하는 화장료 조성물 및 이의 제조방법 |
PL2296672T3 (pl) * | 2008-06-11 | 2016-03-31 | Fresenius Medical Care Deutschland Gmbh | Wzbogacone podłoże progenitorowych komórek wątroby |
WO2009157558A1 (ja) | 2008-06-26 | 2009-12-30 | 科研製薬株式会社 | 鼓膜または外耳道再生剤 |
WO2009158634A2 (en) * | 2008-06-27 | 2009-12-30 | Zimmer Orthobiologics, Inc. | Scaffold coated and/or impregnated with at least one bioactive agent for tissue repair and other medical applications |
ES2668398T3 (es) * | 2008-07-02 | 2018-05-17 | Allergan, Inc. | Composiciones y procedimientos para el relleno y la regeneración de tejidos |
US8357795B2 (en) | 2008-08-04 | 2013-01-22 | Allergan, Inc. | Hyaluronic acid-based gels including lidocaine |
US20100058493A1 (en) * | 2008-08-29 | 2010-03-04 | Arborgen, Llc | Loblolly pine tree named '01NQ0026' |
US8497412B2 (en) * | 2008-08-29 | 2013-07-30 | Arborgen, Llc | Loblolly pine tree named ‘96GE0034’ |
ES2829971T3 (es) | 2008-09-02 | 2021-06-02 | Tautona Group Lp | Hilos de ácido hialurónico y/o derivados de los mismos, métodos para fabricar los mismos y usos de los mismos |
JP5702723B2 (ja) | 2008-09-04 | 2015-04-15 | ザ ジェネラル ホスピタル コーポレイション | 声帯および軟組織の増強および修復用ヒドロゲル |
WO2010038232A1 (en) * | 2008-10-05 | 2010-04-08 | Hymie Friedlander | Extract from conditioned medium cultured by regenerative cells |
US20100305397A1 (en) * | 2008-10-06 | 2010-12-02 | Allergan Medical Sarl | Hydraulic-mechanical gastric band |
US8431801B2 (en) * | 2008-10-08 | 2013-04-30 | Arborgen Inc. | Loblolly pine tree named ‘01PM0212’ |
US20100185049A1 (en) | 2008-10-22 | 2010-07-22 | Allergan, Inc. | Dome and screw valves for remotely adjustable gastric banding systems |
AU2009314506B2 (en) | 2008-11-14 | 2015-07-23 | Histogen, Inc. | Extracellular matrix compositions for the treatment of cancer |
KR20100054711A (ko) * | 2008-11-14 | 2010-05-25 | 메디포스트(주) | 간엽 줄기세포 또는 이의 배양액을 포함하는 신경질환의 예방 또는 치료용 조성물 |
US20100143313A1 (en) * | 2008-12-10 | 2010-06-10 | The General Hospital Corporation | Homogeneous differentiation of hepatocyte-like cells from embryonic stem cells |
EP2198873A1 (de) * | 2008-12-18 | 2010-06-23 | Aposcience AG | Pharmazeutisches Präparat, enthaltend den Überstand einer Blutmononuklearzellkultur |
AU2009327384B2 (en) | 2008-12-19 | 2014-07-10 | DePuy Synthes Products, LLC | Treatment of lung and pulmonary diseases and disorders |
DK2379087T3 (da) * | 2008-12-19 | 2014-11-10 | Depuy Synthes Products Llc | Celler, der stammer fra navlestrengsvæv, til behandling af neuropatisk smerte og spasticitet |
US10179900B2 (en) * | 2008-12-19 | 2019-01-15 | DePuy Synthes Products, Inc. | Conditioned media and methods of making a conditioned media |
AU2009327383B2 (en) * | 2008-12-19 | 2014-08-28 | DePuy Synthes Products, LLC | Regeneration and repair of neural tissue following injury |
DK2379122T3 (en) * | 2008-12-24 | 2015-08-03 | Augustinus Bader | FAST PRODUCTION AND USE OF genetically engineered CELLS AND STRUCTURES AS INDIVIDUAL IMPLANTS |
US8771677B2 (en) * | 2008-12-29 | 2014-07-08 | Vladimir B Serikov | Colony-forming unit cell of human chorion and method to obtain and use thereof |
WO2010093848A1 (en) * | 2009-02-13 | 2010-08-19 | Invitrx, Inc. | Skin cream |
KR101422690B1 (ko) * | 2009-02-27 | 2014-07-23 | (주)차바이오앤디오스텍 | 배아줄기세포 유래 혈관형성전구세포의 배양 분비물을 포함하는 피부재생용 조성물 및 이의 용도 |
US8574902B2 (en) | 2009-03-05 | 2013-11-05 | Macrocure Ltd. | Activated leukocyte composition and uses for wound healing |
KR101078419B1 (ko) * | 2009-03-20 | 2011-10-31 | 주식회사 스템메디언스 | 양수 내 태아 유래 중간엽줄기세포를 이용한 피부 상태개선용 조성물 |
EP2411504B1 (de) | 2009-03-26 | 2017-05-10 | DePuy Synthes Products, Inc. | Humane nabelschnur gewebezellen in der alzheimer therapie |
FI20095355A0 (fi) * | 2009-04-01 | 2009-04-01 | Helsingin Yliopisto | Regeneroituva aktiivinen matriisi ja sen käytöt |
KR101422453B1 (ko) * | 2009-04-16 | 2014-07-28 | (주)차바이오앤디오스텍 | 제대혈 줄기세포 유래 혈관전구세포 배양액 또는 배양 분비물을 이용한 피부재생용 조성물 및 이의 용도 |
US8390326B2 (en) * | 2009-05-05 | 2013-03-05 | William Marsh Rice University | Method for fabrication of a semiconductor element and structure thereof |
CA2767600C (en) * | 2009-07-10 | 2022-05-31 | Histogen, Inc. | Conditioned medium and extracellular matrix compositions from cells cultured under hypoxic conditions |
EP2456862A4 (de) * | 2009-07-20 | 2013-02-27 | Janssen Biotech Inc | Differenzierung menschlicher embryonischer stammzellen |
US20120171172A1 (en) * | 2009-09-04 | 2012-07-05 | Maria Siemionow | Methods Of Engineering Neural Tissue |
GB0916370D0 (en) * | 2009-09-18 | 2009-10-28 | Avecia Biolog Ltd | Compositions |
US8790710B1 (en) | 2009-10-02 | 2014-07-29 | Novo Solutions, MD, L.L.C. | Topical composition comprising umbilical cord blood serum |
WO2011072119A2 (en) * | 2009-12-10 | 2011-06-16 | The Research Foundation Of State University Of Newyork | Stem-cell material and method of use |
US20110172180A1 (en) | 2010-01-13 | 2011-07-14 | Allergan Industrie. Sas | Heat stable hyaluronic acid compositions for dermatological use |
US20110171286A1 (en) * | 2010-01-13 | 2011-07-14 | Allergan, Inc. | Hyaluronic acid compositions for dermatological use |
US9114188B2 (en) | 2010-01-13 | 2015-08-25 | Allergan, Industrie, S.A.S. | Stable hydrogel compositions including additives |
US20110171311A1 (en) * | 2010-01-13 | 2011-07-14 | Allergan Industrie, Sas | Stable hydrogel compositions including additives |
BR112012017463A2 (pt) * | 2010-01-14 | 2015-09-15 | Organogenesis Inc | constructos de tecido de bioengenharia e métodos para sua produção e uso |
MD191Z5 (ro) * | 2010-01-21 | 2010-11-30 | Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова | Mediu nutritiv pentru cultivarea celulelor de origine animală |
US20120315259A1 (en) * | 2010-02-18 | 2012-12-13 | Hyman Friedlander | Method and composition for skin care comprising cord blood serum or plasma or components thereof |
KR20110097064A (ko) * | 2010-02-24 | 2011-08-31 | (주) 아크스템 | 무혈청 줄기 세포 배양 조성물, 이를 함유한 조직 재생용 조성물 및 이를 이용한 조직 재생 방법 |
US8840541B2 (en) | 2010-02-25 | 2014-09-23 | Apollo Endosurgery, Inc. | Pressure sensing gastric banding system |
US9198568B2 (en) | 2010-03-04 | 2015-12-01 | The General Hospital Corporation | Methods and systems of matching voice deficits with a tunable mucosal implant to restore and enhance individualized human sound and voice production |
FR2957254B1 (fr) | 2010-03-12 | 2016-10-14 | Allergan Ind Sas | Compositions fluides pour ameliorer les etats de la peau |
PL2550027T5 (pl) | 2010-03-22 | 2019-07-31 | Allergan, Inc. | Polisacharydowe i białkowo-polisacharydowe usieciowane hydrożele do powiększania tkanek miękkich |
US8911963B2 (en) * | 2010-04-05 | 2014-12-16 | Medstar Health Research Institute, Inc. | Conditioned medium obtained from stem cells and its use in therapy |
US9028394B2 (en) | 2010-04-29 | 2015-05-12 | Apollo Endosurgery, Inc. | Self-adjusting mechanical gastric band |
US20110270024A1 (en) | 2010-04-29 | 2011-11-03 | Allergan, Inc. | Self-adjusting gastric band having various compliant components |
US9044298B2 (en) | 2010-04-29 | 2015-06-02 | Apollo Endosurgery, Inc. | Self-adjusting gastric band |
US8877494B2 (en) * | 2010-06-04 | 2014-11-04 | Ahmed H. Al-Qahtani | Human corneal epithelial cell line PTA-120527 |
US20110300097A1 (en) * | 2010-06-04 | 2011-12-08 | Al-Qahtani Ahmed H | Method And Composition For The Treatment Of Moderate To Severe Keratoconjunctivitis Sicca |
US8517915B2 (en) | 2010-06-10 | 2013-08-27 | Allergan, Inc. | Remotely adjustable gastric banding system |
CN101879329A (zh) * | 2010-06-21 | 2010-11-10 | 蒋明军 | 含基底膜的人工皮肤构建方法及人工皮肤 |
US8697057B2 (en) | 2010-08-19 | 2014-04-15 | Allergan, Inc. | Compositions and soft tissue replacement methods |
US8889123B2 (en) | 2010-08-19 | 2014-11-18 | Allergan, Inc. | Compositions and soft tissue replacement methods |
US8883139B2 (en) | 2010-08-19 | 2014-11-11 | Allergan Inc. | Compositions and soft tissue replacement methods |
US9005605B2 (en) | 2010-08-19 | 2015-04-14 | Allergan, Inc. | Compositions and soft tissue replacement methods |
JP2013536252A (ja) | 2010-08-27 | 2013-09-19 | ファイブロセル テクノロジーズ, インコーポレイテッド | 局所皮膚製剤 |
US20120059216A1 (en) | 2010-09-07 | 2012-03-08 | Allergan, Inc. | Remotely adjustable gastric banding system |
US9168287B2 (en) * | 2010-09-09 | 2015-10-27 | Macrocure, Ltd. | Activated leukocyte conditioned supernatant and uses for wound healing |
US9725689B2 (en) | 2010-10-08 | 2017-08-08 | Terumo Bct, Inc. | Configurable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system |
US8765121B2 (en) | 2010-10-14 | 2014-07-01 | Fibrocell Technologies, Inc. | Treatment of vocal cords with autologous dermal fibroblast formulation |
KR20140018371A (ko) | 2010-11-12 | 2014-02-12 | 알러간, 인코포레이티드 | 물질대사된 조건화 성장 배지 및 이용 방법 |
RU2455354C1 (ru) * | 2010-12-29 | 2012-07-10 | Антонина Ивановна Колесникова | Композиция для регенерации клеток кожи и слизистых оболочек |
ES2647471T3 (es) | 2011-01-18 | 2017-12-21 | Noveome Biotherapeutics, Inc. | Dispositivo y procedimiento para la curación de heridas |
JP5784754B2 (ja) | 2011-02-02 | 2015-09-24 | メディポスト・カンパニー・リミテッドMedipost Co., Ltd. | 神経疾患の予防または処置のためのicam−1の使用 |
US9119974B2 (en) * | 2011-03-04 | 2015-09-01 | Ahmed H. Al-Qahtani | Skin cream |
EP2680865B1 (de) * | 2011-03-04 | 2017-04-26 | Al-Qahtani, Ahmed H. | Hautcreme |
KR101349183B1 (ko) * | 2011-03-14 | 2014-01-08 | 서울대학교산학협력단 | 3차원 세포배양으로 수득한 조건 배지를 유효성분으로 포함하는 허혈성 질환 치료용 약학적 조성물 |
US9446075B2 (en) | 2011-05-06 | 2016-09-20 | Bioregenerative Sciences | Compositions derived from stem cell released molecules and methods for formulation thereof |
US9408797B2 (en) | 2011-06-03 | 2016-08-09 | Allergan, Inc. | Dermal filler compositions for fine line treatment |
US9393263B2 (en) | 2011-06-03 | 2016-07-19 | Allergan, Inc. | Dermal filler compositions including antioxidants |
US20130096081A1 (en) | 2011-06-03 | 2013-04-18 | Allergan, Inc. | Dermal filler compositions |
CN107412002A (zh) | 2011-06-03 | 2017-12-01 | 阿勒根公司 | 包括抗氧化剂的皮肤填充剂组合物 |
CN102266586B (zh) * | 2011-06-28 | 2013-12-04 | 江苏省人民医院 | 白癜风黑素细胞移植涂布载体系统的制备方法 |
US20130244943A1 (en) | 2011-09-06 | 2013-09-19 | Allergan, Inc. | Hyaluronic acid-collagen matrices for dermal filling and volumizing applications |
US9662422B2 (en) | 2011-09-06 | 2017-05-30 | Allergan, Inc. | Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation |
US8876694B2 (en) | 2011-12-07 | 2014-11-04 | Apollo Endosurgery, Inc. | Tube connector with a guiding tip |
US8961394B2 (en) | 2011-12-20 | 2015-02-24 | Apollo Endosurgery, Inc. | Self-sealing fluid joint for use with a gastric band |
US9611513B2 (en) | 2011-12-23 | 2017-04-04 | DePuy Synthes Products, Inc. | Detection of human umbilical cord tissue derived cells |
US9782440B2 (en) * | 2012-02-16 | 2017-10-10 | The Cleveland Clinic Foundation | Methods for treating genitourinary disorders |
KR102126331B1 (ko) * | 2012-02-23 | 2020-06-25 | 주식회사 탑셀바이오 | 컨디션드 배지 분말의 제조방법 |
CA2866563A1 (en) | 2012-03-07 | 2013-09-12 | Fibrocell Technologies, Inc. | Topical dermal formulations and methods of personalized treatment of skin |
US20130244948A1 (en) * | 2012-03-15 | 2013-09-19 | Scharp Technologies, Inc. | Compositions of cells, media, and methods thereof |
CN102600057B (zh) * | 2012-03-16 | 2013-05-01 | 广州赛莱拉生物科技有限公司 | 人胎盘干细胞提取物冻干粉及其制备方法与应用 |
US11744856B1 (en) * | 2012-04-11 | 2023-09-05 | Medicell Technologies, Llc | Compositions and methods to improve skin quality and appearance, cure skin and tissue damage, and use in therapy |
US9445980B2 (en) * | 2012-04-18 | 2016-09-20 | Mark Laney | Methods for stimulating hair growth |
RU2530614C2 (ru) * | 2012-05-04 | 2014-10-10 | Владимир Петрович Швецов | Биологический активный комплекс для органогенеза и продукт секреции клеток, содержащихся в этом комплексе |
US9545370B2 (en) | 2012-05-08 | 2017-01-17 | BioRegenerative Sciences, Inc. | Bioactive compositions and methods for their preparation and use |
US9354237B2 (en) | 2012-05-18 | 2016-05-31 | Purdue Research Foundation | Methods for isolating proteins |
EP2682168A1 (de) | 2012-07-02 | 2014-01-08 | Millipore Corporation | Reinigung biologischer Moleküle |
RU2665793C2 (ru) * | 2012-07-24 | 2018-09-04 | Ниссан Кемикал Индастриз, Лтд. | Композиция культуральной среды и способ культивирования клетки или ткани с использованием указанной композиции |
RU2512681C2 (ru) * | 2012-08-22 | 2014-04-10 | Антонина Ивановна Колесникова | Способ лечения длительно незаживающей раны и/или раневой полости |
US9220817B2 (en) * | 2013-03-13 | 2015-12-29 | Stemnion, Inc. | Medical device |
ES2778098T3 (es) * | 2013-03-13 | 2020-08-07 | Univ Miami | Método de aislamiento y purificación de microvesículas de sobrenadantes de cultivo celular y fluidos biológicos |
WO2014153294A1 (en) * | 2013-03-17 | 2014-09-25 | The Regents Of The University Of California | Method to expand and transduce cultured human small and large intestinal stem cells |
CN105246494B (zh) * | 2013-04-19 | 2020-02-07 | 高丽大学校产学协力团 | 刺激毛发生长或防止毛发脱落的包括神经干细胞的提取物的组合物及其制造方法 |
EP2801613A1 (de) | 2013-05-08 | 2014-11-12 | Ecole Polytechnique Fédérale de Lausanne (EPFL) | Anordnungen abgetrennter Zellkultur-Mikroumgebungen, Verfahren zur Herstellung solcher Anordnungen und Verwendungen davon |
RU2526814C1 (ru) * | 2013-06-17 | 2014-08-27 | Государственное бюджетное учреждение здравоохранения города Москвы Научно-исследовательский институт скорой помощи имени Н.В. Склифосовского Департамента здравоохранения г. Москвы | Способ восстановления кожного покрова у пациентов с обширными ранами с дефектом мягких тканей (варианты) |
CA2930556A1 (en) * | 2013-11-14 | 2015-05-21 | Dermarche Labs, Llc | Fibroblast mixtures and methods of making and using the same |
CN105992816B (zh) | 2013-11-16 | 2018-04-17 | 泰尔茂比司特公司 | 生物反应器中的细胞扩增 |
CN103736080B (zh) * | 2013-11-29 | 2016-06-22 | 焦阳 | 用于伤口愈合的制剂、制备方法及其用途 |
GB201322869D0 (en) | 2013-12-23 | 2014-02-12 | Ucl Business Plc | Therapeutic agents and delivery with microspheres |
WO2015103524A1 (en) * | 2014-01-05 | 2015-07-09 | David Muller | Systems and methods for producing and applying tissue-related structures |
US9907745B2 (en) | 2014-01-15 | 2018-03-06 | Serucell Corporation | Cosmetic compositions and method of making the same |
US9974813B1 (en) | 2014-01-15 | 2018-05-22 | Serucell Corporation | Therapeutic serum obtained from co-cultured cells |
US10533191B2 (en) | 2014-01-15 | 2020-01-14 | Serucell Corporation | Therapeutic serum obtained from co-cultured cells |
US10047344B2 (en) * | 2014-02-18 | 2018-08-14 | National University Of Singapore | Biophysically sorted osteoprogenitors from culture expanded bone marrow derived mesenchymal stromal cells (MSCs) |
TWI558421B (zh) * | 2014-03-06 | 2016-11-21 | 芯芮生技開發股份有限公司 | 幹細胞條件培養基用於製備抑制氧化作用達到皮膚抗老化之組成物的用途 |
KR101623189B1 (ko) * | 2014-03-14 | 2016-05-20 | (주)세포바이오 | 중간엽 줄기세포 유래 단백질을 함유하는 조직 재생용 조성물 |
EP3122866B1 (de) | 2014-03-25 | 2019-11-20 | Terumo BCT, Inc. | Passives ersetzen von medien |
US9284528B2 (en) | 2014-04-18 | 2016-03-15 | Growgene Biotech Inc. | Use of stem cell conditioned medium to inhibit oxidation for anti-aging skin |
US20150328263A1 (en) * | 2014-05-14 | 2015-11-19 | University Of Maryland, Baltimore | Cardiac stem cells for cardiac repair |
WO2016006788A1 (ko) * | 2014-07-07 | 2016-01-14 | 메디포스트(주) | 작은 크기 줄기세포의 발모 촉진능 및 이의 용도 |
WO2016044555A1 (en) | 2014-09-17 | 2016-03-24 | Massachusetts Institute Of Technology | System and method for inertial focusing microfiltration for intra-operative blood salvage autotransfusion |
EP3198006B1 (de) | 2014-09-26 | 2021-03-24 | Terumo BCT, Inc. | Geplante fütterung |
RU2574017C1 (ru) * | 2014-09-30 | 2016-01-27 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) | Средство для лечения ожогов и ран на основе цитокинов и факторов роста, секретируемых мезенхимными клетками человека, способ получения средства и способ лечения ожогов и ран |
US10722444B2 (en) | 2014-09-30 | 2020-07-28 | Allergan Industrie, Sas | Stable hydrogel compositions including additives |
CN107208025A (zh) | 2014-11-25 | 2017-09-26 | 康宁股份有限公司 | 延续细胞培养基的材料和方法 |
US10842735B2 (en) | 2014-11-28 | 2020-11-24 | Dong Hyun AHN | Hair growth-promoting composition |
KR101570004B1 (ko) * | 2014-11-28 | 2015-11-17 | 안동현 | 발모촉진용 조성물 |
RU2644650C2 (ru) | 2014-12-01 | 2018-02-13 | Общество с ограниченной ответственностью "Т-Хелпер Клеточные Технологии" | Материал стволовых клеток и способ его получения |
WO2016128783A1 (en) | 2015-02-09 | 2016-08-18 | Allergan Industrie Sas | Compositions and methods for improving skin appearance |
RU2745413C2 (ru) * | 2015-06-04 | 2021-03-24 | Фондационе Ирккс Ка' Гранда - Оспедале Маджоре Поликлинико | Система из множества пакетов и способ приготовления компонентов крови |
RU2587755C1 (ru) * | 2015-06-10 | 2016-06-20 | Федеральное государственное бюджетное учреждение "Государственный научный центр Российской Федерации - Федеральный Медицинский биофизический центр имени А.И. Бурназяна Федерального Медико-биологического агентства" (ФГБУ ГНЦ ФМБЦ им. А.И. Бурназяна ФМБА России) | Способ получения действующего вещества из пантов марала |
BE1023155B1 (nl) | 2015-06-30 | 2016-12-02 | Guido Wouters | Samenstelling voor wondheling |
WO2017004592A1 (en) | 2015-07-02 | 2017-01-05 | Terumo Bct, Inc. | Cell growth with mechanical stimuli |
CN108289927A (zh) * | 2015-11-30 | 2018-07-17 | 德玛福斯控股有限责任公司 | 含有蛋白的外用皮肤组合物和使用方法 |
US11254915B2 (en) | 2015-12-11 | 2022-02-22 | Lei Guo | Method for separating and culturing mesenchymal stem cells from Wharton's jelly tissue of umbilical cord |
WO2017096616A1 (zh) * | 2015-12-11 | 2017-06-15 | 郭镭 | 一种无血清培养基及其制备方法和用途 |
RU2620167C1 (ru) * | 2015-12-21 | 2017-05-23 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) | Способ получения средства для стимуляции регенерации на основе продуктов секреции мультипотентных мезенхимных стромальных клеток человека |
CN108699512A (zh) * | 2016-02-22 | 2018-10-23 | 国立大学法人大阪大学 | 立体细胞组织的制造方法 |
US11071706B2 (en) | 2016-04-01 | 2021-07-27 | Biocoz Global Korea Corp. | Cosmetic composition containing, as active ingredient, albumin, hyaluronic acid or collagen in cell culture medium |
US10894947B1 (en) * | 2016-04-29 | 2021-01-19 | Hope Biosciences, Llc | Method for generating protein rich conditioned medium |
US11111480B2 (en) | 2016-04-29 | 2021-09-07 | Hope Biosctences, Llc | Culture media for multipotent stem cells |
RU2620342C1 (ru) * | 2016-05-11 | 2017-05-24 | Общество С Ограниченной Ответственностью "Генная И Клеточная Терапия" (Ооо "Генная И Клеточная Терапия") | Косметическое средство на основе продуктов секреции мезенхимных стволовых/стромальных клеток жировой ткани человека и способ его получения |
WO2017197262A1 (en) * | 2016-05-12 | 2017-11-16 | Insitu Biologics, Llc | Hydrogel-based biological delivery vehicle |
RU2708329C2 (ru) | 2016-05-31 | 2019-12-05 | Общество с ограниченной ответственностью "Т-Хелпер Клеточные Технологии" | Материал стволовых клеток, композиции и способы применения |
US11104874B2 (en) | 2016-06-07 | 2021-08-31 | Terumo Bct, Inc. | Coating a bioreactor |
US11685883B2 (en) | 2016-06-07 | 2023-06-27 | Terumo Bct, Inc. | Methods and systems for coating a cell growth surface |
CN106754669B (zh) * | 2016-11-23 | 2020-04-17 | 河海大学常州校区 | 基于反应-扩散模型的多细胞结构的制备方法及制备系统 |
RU2644278C1 (ru) * | 2016-12-21 | 2018-02-08 | Федеральное государственное автономное учреждение "Национальный медицинский исследовательский центр нейрохирургии имени академика Н.Н.Бурденко" Министерства здравоохранения Российской Федерации (ФГАУ "НМИЦ нейрохирургии им. акад. Н.Н.Бурденко" Минздрава России | Способ микрохирургической реконструкции спинного мозга на животной модели с использованием биодеградируемого гидрогеля на основе поливинилового спирта |
AR111512A1 (es) * | 2017-02-23 | 2019-07-24 | Japan Vam & Poval Co Ltd | Dispositivo de integración celular o tisular |
US11702634B2 (en) | 2017-03-31 | 2023-07-18 | Terumo Bct, Inc. | Expanding cells in a bioreactor |
KR102544417B1 (ko) * | 2017-03-31 | 2023-06-16 | 셀룸 바이오메디컬, 인크. | 생체 적합성의 조건화된 세포 배지 조성물 및 그의 용도 |
US11624046B2 (en) | 2017-03-31 | 2023-04-11 | Terumo Bct, Inc. | Cell expansion |
JP6438527B2 (ja) * | 2017-06-01 | 2018-12-12 | Ncメディカルリサーチ株式会社 | 神経変性の治療のための細胞療法 |
CN107261213A (zh) * | 2017-06-13 | 2017-10-20 | 北京恒峰铭成生物科技有限公司 | 一种活性水凝胶及其制备方法和在手术创伤修复中的应用 |
US11718829B2 (en) | 2017-07-28 | 2023-08-08 | Breakthrough Tech Llc | Methods and compositions for manufacturing extracellular matrix |
US11696929B2 (en) | 2017-09-20 | 2023-07-11 | The Regents Of The University Of California | Methods and systems for conserving highly expanded cells |
WO2019140267A1 (en) * | 2018-01-12 | 2019-07-18 | Histogen, Inc. | Nutraceutical products from cell conditioned medium from cells cultured under hypoxic conditions |
CN108486045A (zh) * | 2018-01-23 | 2018-09-04 | 广东颜值科技有限公司 | 一种人成纤维细胞的培养组合物 |
FR3078541B1 (fr) * | 2018-03-05 | 2022-07-08 | Genoskin | Modele d’injection sous-cutanee ex vivo |
RU2716159C2 (ru) * | 2018-03-06 | 2020-03-06 | Андрей Александрович Темнов | Композиция для профилактического или терапевтического лечения состояний, связанных с изменением количества волос |
AU2019276713A1 (en) * | 2018-05-30 | 2021-01-21 | Direct Biologics Llc | A growth factor and extracellular vesicle frozen or powdered additive comprising a mesenchymal stem cell (MSC) preparation and methods of use |
US11369718B1 (en) * | 2018-08-24 | 2022-06-28 | Ariasa LLC | Method and use of cryopreserved mesenchymal stem cells via liquid suspension from the amniotic sac for rejuvenation of the midface |
WO2020130800A1 (en) * | 2018-12-21 | 2020-06-25 | Cytonex Sdn. Bhd. | Stem cell conditioned media |
US10881693B2 (en) | 2019-04-09 | 2021-01-05 | Combangio, Inc. | Processes for making and using a mesenchymal stem cell derived secretome |
US20220211768A1 (en) * | 2019-05-02 | 2022-07-07 | Histogen, Inc. | Conditioned medium and methods of use thereof |
US11065188B2 (en) | 2019-05-29 | 2021-07-20 | Av Laboratories Llc | Applications and formulations of optimized, modified human embryonic fertility culture media with biguanides and/or functional equivalents |
AU2020327956A1 (en) * | 2019-08-09 | 2022-02-03 | Axolotl Biologix, Inc. | Compositions derived from human amnion cells and related methods |
WO2021055579A1 (en) * | 2019-09-19 | 2021-03-25 | Life Technologies Corporation | Cell culture media tablets and methods of manufacture |
CN110607279B (zh) * | 2019-10-18 | 2023-09-19 | 深圳优圣康医学检验实验室 | 一种原代肿瘤细胞的3d培养体系及其培养方法和应用 |
CN112980796A (zh) * | 2019-12-17 | 2021-06-18 | 东莞市东阳光生物药研发有限公司 | 用于降低cho细胞中表达重组蛋白的氧化的液体培养基 |
CN111658672A (zh) * | 2020-06-20 | 2020-09-15 | 河南和泽干细胞基因工程有限公司 | 一种人胎盘干细胞提取物冻干粉及其制备方法 |
US20230000954A1 (en) | 2021-07-02 | 2023-01-05 | Combangio, Inc. | Processes for making and using a cellular fibronectin composition |
US20230043556A1 (en) | 2021-07-30 | 2023-02-09 | L'oreal | Compositions comprising extracellular vesicles, secreted biomolecules, and/or conditioned media, and methods of producing and using the same |
FR3126617A1 (fr) | 2021-09-06 | 2023-03-10 | L'oreal | compositions comprenant des vésicules extracellulaires, des biomolécules sécrétées et/ou des milieux conditionnés, et procédés pour les produire |
CN115074322B (zh) * | 2022-07-01 | 2024-01-26 | 江南大学 | 一种高效获取多种生物活性功能因子的鼻黏膜外胚层间充质干细胞三维培养方法 |
BR102022016233A2 (pt) * | 2022-08-16 | 2024-02-27 | Omics Biotecnologia Animal Ltda | Concentrado de proteínas e peptídeos derivados de células estromais mesenquimais, método de obtenção e uso de concentrado |
CN115518198B (zh) * | 2022-10-11 | 2024-01-16 | 青岛大学 | 一种负载双向梯度ecm涂层的血管修复支架及其制备方法 |
Family Cites Families (107)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2004A (en) * | 1841-03-12 | Improvement in the manner of constructing and propelling steam-vessels | ||
US2007A (en) * | 1841-03-16 | Improvement in the mode of harvesting grain | ||
US564381A (en) * | 1896-07-21 | Prune or fruit dipper | ||
US4458678A (en) | 1981-10-26 | 1984-07-10 | Massachusetts Institute Of Technology | Cell-seeding procedures involving fibrous lattices |
US4485096A (en) | 1982-02-26 | 1984-11-27 | Massachusetts Institute Of Technology | Tissue-equivalent and method for preparation thereof |
ES8503941A1 (es) * | 1982-10-27 | 1985-04-16 | Crinos Industria Farmaco | Procedimiento de obtencion de composiciones para promover el trofismo de la piel y de foliculos piliferosos relacionados |
US4911720A (en) | 1983-03-10 | 1990-03-27 | Collier John P | Particular surface replacement prosthesis |
JPS6133124A (ja) * | 1983-11-04 | 1986-02-17 | ラルフ シルヴア−マン | 異性々疾患を治療するための培養間葉細胞から抽出した巨大分子 |
US4757017A (en) * | 1984-09-14 | 1988-07-12 | Mcw Research Foundation, Inc. | In vitro cell culture system |
US4861714A (en) * | 1985-04-04 | 1989-08-29 | Verax Corporation | Weighted collagen microsponge for immobilizing bioactive material |
US4806523A (en) * | 1985-08-06 | 1989-02-21 | Collagen Corporation | Method of treating inflammation |
FR2586703B1 (fr) | 1985-09-02 | 1989-12-01 | Merieux Inst | Procede d'extraction de collagenes placentaires, collagenes obtenus notamment sous forme de gels ou de solutions et leurs applications |
CA1282725C (en) * | 1986-04-18 | 1991-04-09 | Brian A. Naughton | Process for replicating bone marrow in vitro and using the same |
US4963489A (en) | 1987-04-14 | 1990-10-16 | Marrow-Tech, Inc. | Three-dimensional cell and tissue culture system |
US5902741A (en) * | 1986-04-18 | 1999-05-11 | Advanced Tissue Sciences, Inc. | Three-dimensional cartilage cultures |
US5266480A (en) | 1986-04-18 | 1993-11-30 | Advanced Tissue Sciences, Inc. | Three-dimensional skin culture system |
US5863531A (en) * | 1986-04-18 | 1999-01-26 | Advanced Tissue Sciences, Inc. | In vitro preparation of tubular tissue structures by stromal cell culture on a three-dimensional framework |
US5460939A (en) * | 1986-04-18 | 1995-10-24 | Advanced Tissue Sciences, Inc. | Temporary living skin replacement |
US5032508A (en) | 1988-09-08 | 1991-07-16 | Marrow-Tech, Inc. | Three-dimensional cell and tissue culture system |
US5565347A (en) * | 1986-06-10 | 1996-10-15 | Calgene, Inc. | Transformation and foreign gene expression with plant species |
JPH0618781B2 (ja) * | 1986-10-18 | 1994-03-16 | 中外製薬株式会社 | 感染症治療剤 |
US5804178A (en) | 1986-11-20 | 1998-09-08 | Massachusetts Institute Of Technology | Implantation of cell-matrix structure adjacent mesentery, omentum or peritoneum tissue |
US5736372A (en) | 1986-11-20 | 1998-04-07 | Massachusetts Institute Of Technology | Biodegradable synthetic polymeric fibrous matrix containing chondrocyte for in vivo production of a cartilaginous structure |
CA1340581C (en) | 1986-11-20 | 1999-06-08 | Joseph P. Vacanti | Chimeric neomorphogenesis of organs by controlled cellular implantation using artificial matrices |
US4885163A (en) * | 1987-02-24 | 1989-12-05 | Eli Lilly And Company | Topical use of IGF-II for wound healing |
KR0131822B1 (ko) * | 1988-05-23 | 1998-04-11 | 죤 에프. 튜은트 | 바이오 반응기 장치 |
GEP20022681B (en) * | 1989-01-31 | 2002-04-25 | Aaronson Us Stuart A | Protein KFG, Antibodies, Pharmaceutical Composition, Their Use, recombinant DNA, Cell, Method for Discoveries and Production of Proteins, Method for Stimulation of Epithelial Cells Growth |
US5693625A (en) * | 1989-03-09 | 1997-12-02 | Therapeutiques Substitutives | Method of regenerating cells and tissues using functionalized dextrans |
US5091173A (en) * | 1989-06-29 | 1992-02-25 | The University Of Dundee | Hair growth composition |
US5830709A (en) * | 1989-10-27 | 1998-11-03 | Benson; Roger E. | Detection method for homologous portions of a class of substances |
US5292655A (en) * | 1990-01-29 | 1994-03-08 | Wille Jr John J | Method for the formation of a histologically-complete skin substitute |
ATE161408T1 (de) | 1990-04-24 | 1998-01-15 | Mark Eisenberg | Zusammengesetztes äquivalent der lebenden haut |
CA2051796A1 (en) | 1990-09-21 | 1992-03-22 | Marvin L. Bayne | Vascular endothelial cell growth factor ii |
US5478560A (en) * | 1990-10-19 | 1995-12-26 | Shiseido Company Ltd. | External dermatological composition |
US5229493A (en) | 1990-10-26 | 1993-07-20 | Children's Medical Center Corporation | Smooth muscle mitogen |
US7196054B1 (en) | 1990-11-27 | 2007-03-27 | The American National Red Cross | Methods for treating wound tissue and forming a supplemented fibrin matrix |
US5763367A (en) * | 1991-03-28 | 1998-06-09 | Bottom Line Industries, Inc. | Well fluid additive, well fluid made therefrom, method of treating a well fluid, method of circulating a well fluid |
CA2089653A1 (en) | 1991-06-17 | 1992-12-18 | Dennis M. Disorbo | Media concentrate technology |
WO1993004164A1 (en) * | 1991-08-26 | 1993-03-04 | THE STATE OF OREGON acting by and through THE STATE OF BOARD OF HIGHER EDUCATION on behalf of THE OREGON HEALTH SCIENCES UNIVERSITY | Keratinocyte-derived conditioned medium as a source of growth factors |
US6324404B1 (en) * | 1991-12-26 | 2001-11-27 | Sycord Limited Partnership | Cellular telephone system that uses position of a mobile unit to make call management decisions |
US5235633A (en) * | 1991-12-26 | 1993-08-10 | Everett Dennison | Cellular telephone system that uses position of a mobile unit to make call management decisions |
ES2153378T3 (es) | 1992-02-28 | 2001-03-01 | Univ Texas | Hidrogeles biodegradables fotopolimerizables como materiales de contacto de tejidos y portadores de descarga controlada. |
US5255307A (en) * | 1992-05-07 | 1993-10-19 | Sony Electronics Inc. | Status indicator control for cellular mobile telephone system |
US5618544A (en) | 1992-08-12 | 1997-04-08 | Bays-Brown Dermatologics, Inc. | Method of decreasing cutaneous senescence |
US5774193A (en) | 1992-10-05 | 1998-06-30 | Vaughan; Thomas J. | Digital television (HDTV) and analog television (NTSC) broadcast systems combined for simultaneous broadcast |
JPH06133124A (ja) | 1992-10-20 | 1994-05-13 | Fuji Xerox Co Ltd | 画像記録装置 |
US5478739A (en) | 1992-10-23 | 1995-12-26 | Advanced Tissue Sciences, Inc. | Three-dimensional stromal cell and tissue culture system |
RU2054924C1 (ru) | 1992-12-30 | 1996-02-27 | Акционерное общество "Биотехнология" | Препарат для лечения инфицированных вялозаживающих ран и язв |
AU696691C (en) | 1993-03-12 | 2003-09-18 | American National Red Cross, The | Supplemented and unsupplemented tissue sealants, methods of their production and use |
US5407912A (en) * | 1993-04-19 | 1995-04-18 | Akzo, N.V. | Method of treating bladder cancer with a keyhole limpet hemocyanin composition with enhanced anti-tumor activity |
US5709854A (en) | 1993-04-30 | 1998-01-20 | Massachusetts Institute Of Technology | Tissue formation by injecting a cell-polymeric solution that gels in vivo |
RU2063743C1 (ru) | 1993-06-01 | 1996-07-20 | Акционерное общество закрытого типа "Химбио" | Крем для питания, защиты и предотвращения старения кожи |
CA2134729C (en) * | 1993-11-01 | 1999-09-07 | Thomas E. Buss | Location dependent information receiving device and method |
US6084724A (en) | 1993-12-30 | 2000-07-04 | Eastman Kodak Company | Glass coated cemented plastic doublets and method for making |
US5935849A (en) * | 1994-07-20 | 1999-08-10 | Cytotherapeutics, Inc. | Methods and compositions of growth control for cells encapsulated within bioartificial organs |
US5516532A (en) | 1994-08-05 | 1996-05-14 | Children's Medical Center Corporation | Injectable non-immunogenic cartilage and bone preparation |
FI96558C (fi) * | 1994-09-27 | 1996-07-10 | Nokia Telecommunications Oy | Menetelmä datasiirtoa varten TDMA-matkaviestinjärjestelmässä sekä menetelmän toteuttava matkaviestinjärjestelmä |
EP0797874A1 (de) * | 1994-12-12 | 1997-10-01 | Ericsson Inc. | Kanalzuteilung mit rücksicht auf diversität in einer mobilen kommunikationsanordnung |
WO1996018726A1 (en) | 1994-12-15 | 1996-06-20 | THE UNITED STATES GOVERNMENT, represented by THE SECRETARY OF THE NAVY | Compositions and methods for stimulating hematopoietic cell expansion |
US5900245A (en) | 1996-03-22 | 1999-05-04 | Focal, Inc. | Compliant tissue sealants |
US5830708A (en) | 1995-06-06 | 1998-11-03 | Advanced Tissue Sciences, Inc. | Methods for production of a naturally secreted extracellular matrix |
CA2223889A1 (en) | 1995-06-07 | 1996-12-19 | The American National Red Cross | Supplemented and unsupplemented tissue sealants, methods of their production and use |
US5843766A (en) | 1995-06-07 | 1998-12-01 | Advanced Tissue Sciences, Inc. | Apparatus for the growth and packaging of three dimensional tissue cultures |
US5654381A (en) | 1995-06-16 | 1997-08-05 | Massachusetts Institute Of Technology | Functionalized polyester graft copolymers |
GB2304497A (en) * | 1995-08-19 | 1997-03-19 | Northern Telecom Ltd | Cellular communications system with provision of services to visiting mobiles |
JPH11512435A (ja) * | 1995-09-12 | 1999-10-26 | ジェネンテック インコーポレーテッド | 嚢胞性繊維症の治療 |
FR2739621B1 (fr) | 1995-10-05 | 1997-12-05 | Centre Nat Rech Scient | Peptides utilisables comme vecteurs pour l'adressage intracellulaire de molecules actives |
US5965125A (en) * | 1995-10-25 | 1999-10-12 | Transkaryotic Therapies, Inc. | Hybrid matrix implants and explants |
JP2679694B2 (ja) | 1995-11-08 | 1997-11-19 | コクヨ株式会社 | ホルダー |
US5787348A (en) * | 1995-12-06 | 1998-07-28 | Motorola, Inc. | Method of measuring speed of a mobile unit and a receiver for use in a wireless communication system |
US5888551A (en) | 1995-12-11 | 1999-03-30 | University Of Miami | Hair growth stimulating composition |
US6048964A (en) * | 1995-12-12 | 2000-04-11 | Stryker Corporation | Compositions and therapeutic methods using morphogenic proteins and stimulatory factors |
US5708854A (en) * | 1996-01-24 | 1998-01-13 | Eastman Kodak Company | One-time-use camera has driver for closing film cassette which is removed with closed cassette to disable camera after completed use |
US5826014A (en) * | 1996-02-06 | 1998-10-20 | Network Engineering Software | Firewall system for protecting network elements connected to a public network |
US5770448A (en) * | 1996-03-29 | 1998-06-23 | Northwestern University | Human epithelial cell matrix and uses therefor |
US5763267A (en) * | 1996-04-16 | 1998-06-09 | Advanced Tissue Sciences | Apparatus for the large scale growth and packaging of cell suspensions and three-dimensional tissue cultures |
US6132759A (en) * | 1996-05-03 | 2000-10-17 | Innogenetics N.V. | Medicaments containing gelatin cross-linked with oxidized polysaccharides |
US5667791A (en) * | 1996-05-31 | 1997-09-16 | Thione International, Inc. | X-ray induced skin damage protective composition |
US5857201A (en) * | 1996-06-18 | 1999-01-05 | Wright Strategies, Inc. | Enterprise connectivity to handheld devices |
ATE434034T1 (de) | 1996-08-23 | 2009-07-15 | Vegenics Ltd | Rekombinanter vasculärer endothelzellen wachstumsfaktor d (vegf-d) |
US5914668A (en) * | 1996-08-30 | 1999-06-22 | Lucent Technologies Inc. | Wireless terminal controlled mobility operational parameters |
DE69728415T2 (de) | 1996-10-15 | 2004-08-12 | Amgen Inc., Thousand Oaks | Produkte des keratinocyten-wachstumsfaktors 2 (kgf-2) |
WO1998021312A1 (en) | 1996-11-08 | 1998-05-22 | Rpms Technology Limited | Human hepatocytes in three-dimensional support systems |
US6044273A (en) * | 1996-12-10 | 2000-03-28 | Northern Telecom Limited | Method and apparatus for designing a communication system by modeling spatial and temporal behavior of user mobility demand |
US5814328A (en) * | 1997-01-13 | 1998-09-29 | Gunasekaran; Subramanian | Preparation of collagen using papain and a reducing agent |
US5970403A (en) * | 1997-03-04 | 1999-10-19 | Ericsson Inc. | Load based charging within a mobile telecommunications network |
RU2142783C1 (ru) | 1997-03-06 | 1999-12-20 | Децина Анатолий Николаевич | Регенерирующее косметическое средство для ухода за кожей |
US6044261A (en) * | 1997-03-19 | 2000-03-28 | Ericsson, Inc. | Multiple home zone areas within a mobile telecommunications network |
US6224893B1 (en) | 1997-04-11 | 2001-05-01 | Massachusetts Institute Of Technology | Semi-interpenetrating or interpenetrating polymer networks for drug delivery and tissue engineering |
IL121041A0 (en) * | 1997-06-09 | 1997-11-20 | Yeda Res & Dev | Immunogenic compositions for induction of anti-tumor immunity |
US6091956A (en) * | 1997-06-12 | 2000-07-18 | Hollenberg; Dennis D. | Situation information system |
US6070184A (en) * | 1997-08-28 | 2000-05-30 | International Business Machines Corporation | Server-side asynchronous form management |
GB9718609D0 (en) | 1997-09-02 | 1997-11-05 | Imp College Innovations Ltd | Fusion protein |
US6075797A (en) * | 1997-10-17 | 2000-06-13 | 3Com Corporation | Method and system for detecting mobility of a wireless-capable modem to minimize data transfer rate renegotiations |
RU2141814C1 (ru) | 1997-11-28 | 1999-11-27 | Беляков Юрий Иванович | Шампунь на основе молочной сыворотки |
US6291240B1 (en) * | 1998-01-29 | 2001-09-18 | Advanced Tissue Sciences, Inc. | Cells or tissues with increased protein factors and methods of making and using same |
JP4354641B2 (ja) * | 1998-04-03 | 2009-10-28 | テレフオンアクチーボラゲット エル エム エリクソン(パブル) | ユニバーサル移動電話システム(umts)におけるフレキシブル無線アクセス及びリソース割り当て |
US6258782B1 (en) | 1998-05-20 | 2001-07-10 | Trimeris, Inc. | Hybrid polypeptides with enhanced pharmacokinetic properties |
RU2123837C1 (ru) | 1998-05-27 | 1998-12-27 | Бритун Юлия Анатольевна | Способ устранения морщин |
US6169898B1 (en) * | 1998-07-16 | 2001-01-02 | Nokia Mobile Phones Ltd | Apparatus, and associated method, for maintaining a selected quality of service level in a radio communication system |
ATE419273T1 (de) | 1998-11-13 | 2009-01-15 | Cyclacel Ltd | Translokationsvektoren abgeleitet von der antennapedia homeodomain helix 3 |
US6911201B1 (en) | 1999-02-04 | 2005-06-28 | Technion Research & Development Foundation Ltd. | Method of producing undifferentiated hemopoietic stem cells using a stationary phase plug-flow bioreactor |
US6372494B1 (en) * | 1999-05-14 | 2002-04-16 | Advanced Tissue Sciences, Inc. | Methods of making conditioned cell culture medium compositions |
CA2383398C (en) * | 1999-08-23 | 2013-06-11 | Organogenesis, Inc. | Skin care compositions and treatments |
US6463274B1 (en) * | 1999-10-26 | 2002-10-08 | Denso Corporation | Multiple class of service determination for digital cellular telephones |
US6930470B2 (en) * | 2001-03-01 | 2005-08-16 | Nortel Networks Limited | System and method for code division multiple access communication in a wireless communication environment |
WO2002098365A2 (en) | 2001-06-07 | 2002-12-12 | Skinmedica, Inc. | Conditioned cell culture media and uses thereof |
-
1999
- 1999-05-14 US US09/313,538 patent/US6372494B1/en not_active Expired - Lifetime
-
2000
- 2000-05-12 US US09/979,813 patent/US7118746B1/en not_active Expired - Lifetime
- 2000-05-12 RU RU2001133453/13A patent/RU2280459C2/ru active
- 2000-05-12 JP JP2000617908A patent/JP5138129B2/ja not_active Expired - Lifetime
- 2000-05-12 ES ES00930643T patent/ES2254176T3/es not_active Expired - Lifetime
- 2000-05-12 HU HU0201887A patent/HUP0201887A2/hu unknown
- 2000-05-12 AT AT00930643T patent/ATE311894T1/de not_active IP Right Cessation
- 2000-05-12 AU AU48430/00A patent/AU772829C/en not_active Expired
- 2000-05-12 CA CA2373302A patent/CA2373302C/en not_active Expired - Lifetime
- 2000-05-12 EP EP00930643A patent/EP1178812B1/de not_active Expired - Lifetime
- 2000-05-12 NZ NZ515476A patent/NZ515476A/xx not_active IP Right Cessation
- 2000-05-12 CN CNB008103453A patent/CN1198628C/zh not_active Expired - Lifetime
- 2000-05-12 WO PCT/US2000/013016 patent/WO2000069449A2/en active IP Right Grant
- 2000-05-12 DE DE60024612T patent/DE60024612T2/de not_active Expired - Lifetime
- 2000-05-12 MX MXPA01011487A patent/MXPA01011487A/es active IP Right Grant
- 2000-05-12 BR BR0010568-6A patent/BR0010568A/pt not_active Application Discontinuation
-
2001
- 2001-11-14 ZA ZA200109381A patent/ZA200109381B/en unknown
-
2006
- 2006-10-03 US US11/538,380 patent/US8361485B2/en not_active Expired - Fee Related
-
2009
- 2009-01-06 US US12/349,451 patent/US8138147B2/en not_active Expired - Lifetime
-
2012
- 2012-03-09 US US13/417,017 patent/US8476231B2/en not_active Expired - Fee Related
- 2012-09-06 JP JP2012196046A patent/JP5526352B2/ja not_active Expired - Lifetime
-
2013
- 2013-03-15 US US13/842,324 patent/US20130217129A1/en not_active Abandoned
- 2013-03-15 US US13/841,466 patent/US20130210725A1/en not_active Abandoned
- 2013-03-15 US US13/841,139 patent/US20130217069A1/en not_active Abandoned
- 2013-03-15 US US13/841,342 patent/US20130203169A1/en not_active Abandoned
- 2013-03-15 US US13/842,129 patent/US9458486B2/en not_active Expired - Fee Related
- 2013-03-15 US US13/842,243 patent/US20130210076A1/en not_active Abandoned
-
2016
- 2016-10-03 US US15/284,223 patent/US20170055561A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60024612D1 (de) | Verfahren zur herstellung von konditionierten zellkulturmedium-zusammensetzungen | |
GR3025710T3 (en) | Use of mesomorphic phases in food products. | |
BG102708A (en) | 4-aminopyrimidine derivatives, medicamentous preparations containing them, their application and method for their preparation | |
WO2001041800A3 (en) | Compositions and methods for stabilizing biological molecules upon lyophilization | |
AU4718496A (en) | Use of aerogels in agriculture | |
NZ512792A (en) | Stable liquid interferon beta formulations | |
AU5501598A (en) | Triazolo{4,5-(d)}pyrimidinyl derivatives and their use as medicaments | |
WO2001017548A3 (de) | Verwendung natriuretischer peptide als antibiotisch wirksame substanzen zur behandlung von bakteriellen infektionen | |
MXPA03005548A (es) | Metodos para la produccion de proteinas multimericas, y composiciones relacionadas. | |
AU2002221702A1 (en) | Pharmaceutical compositions | |
PL336983A1 (en) | Compounds, their production and application as carriers of nucleic acids in cells | |
WO2004071466A3 (en) | Manufacturing process for liposomal preparations | |
PT1165558E (pt) | Derivados de pirimido¬6,1-a|isoquinolina-4-ona | |
ES2249058T3 (es) | Factores de preservacion de celulas progenitoras y metodos y productos relacionados. | |
CA2157836A1 (en) | L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses | |
AU7914600A (en) | The use of baclofen in the treatment of alcohol withdrawal syndrome and to promote alcohol abstinence in alcoholics | |
DE69431162T2 (de) | Fenbendazolformulierungen | |
WO2001045650A3 (de) | Kosmetische verwendung von rückständen aus der weinherstellung | |
AU6558400A (en) | Stabilisation of freeze-dried cake | |
DE69926881D1 (de) | Zubereitungen zur aknebehandlung | |
GB0010314D0 (en) | Anti-freeze proteins their production and use | |
BG101379A (en) | New pypimido [1,2-a] indoles | |
DE50009804D1 (de) | Vernetzerfreie zubereitungen | |
NZ333412A (en) | Plant proteins treated to reduce isoflavones, manganese and nucleotides and nutritional products made therefrom | |
CA2145536A1 (en) | Spreads |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |